- Home
- SNY vs CRWD Comparison
SNY vs CRWD Comparison
Compare SNY & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- CRWD
- Stock Information
- Founded
- SNY 1994
- CRWD 2011
- Country
- SNY France
- CRWD United States
- Employees
- SNY N/A
- CRWD N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- CRWD EDP Services
- Sector
- SNY Health Care
- CRWD Technology
- Exchange
- SNY Nasdaq
- CRWD Nasdaq
- Market Cap
- SNY 116.5B
- CRWD 123.7B
- IPO Year
- SNY N/A
- CRWD 2019
- Fundamental
- Price
- SNY $48.61
- CRWD $478.11
- Analyst Decision
- SNY Buy
- CRWD Buy
- Analyst Count
- SNY 2
- CRWD 48
- Target Price
- SNY $62.50
- CRWD $453.98
- AVG Volume (30 Days)
- SNY 2.2M
- CRWD 3.2M
- Earning Date
- SNY 07-31-2025
- CRWD 08-27-2025
- Dividend Yield
- SNY 3.29%
- CRWD N/A
- EPS Growth
- SNY 39.56
- CRWD N/A
- EPS
- SNY 5.45
- CRWD N/A
- Revenue
- SNY $48,817,552,946.00
- CRWD $4,136,022,000.00
- Revenue This Year
- SNY $3.39
- CRWD $23.38
- Revenue Next Year
- SNY $7.05
- CRWD $21.77
- P/E Ratio
- SNY $8.92
- CRWD N/A
- Revenue Growth
- SNY N/A
- CRWD 25.94
- 52 Week Low
- SNY $45.80
- CRWD $200.81
- 52 Week High
- SNY $60.12
- CRWD $517.98
- Technical
- Relative Strength Index (RSI)
- SNY 46.26
- CRWD 48.58
- Support Level
- SNY $47.99
- CRWD $497.74
- Resistance Level
- SNY $49.43
- CRWD $514.50
- Average True Range (ATR)
- SNY 0.58
- CRWD 15.34
- MACD
- SNY 0.18
- CRWD -3.09
- Stochastic Oscillator
- SNY 56.15
- CRWD 36.93
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.